IBM Clinical Trial Management System (CTMS) for Sites, formally known as Merge Clinical Trial Management System for Investigators, is a platform used by institutions conducting research to organize, centralize, and manage clinical research operations and finances across their institution. It supports large hospitals and academic organizations as well as independent research organizations. When implemented as part of the central research infrastructure at clinical research sites, CTMS for Sites helps to streamline the clinical trial process and maximizes operational efficiencies. It is designed to reduce financial compliance risk, increase performance transparency across organizations, maximize revenue or cost coverage, reduce burden of duplicate data entry, and support efficient participant recruitment. CTMS for Sites provides a building block for centralization and standardization at research sites and can help create an end-to-end ecosystem that supports clinical care as well as research, regardless of research specialty or site type.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.
MRN specializes in the conduct of clinical trial visits in the patient’s home and supporting clinical trial sites with nursing resources. We believe in reducing the burden of participation on patients and reducing the burden on participation on sites – building more patient-centric clinical trials.
MRN offers two core services in the management of complex clinical trials:
Home Trial Support (HTS) is the conduct of clinical trial visits in the patient’s home. This replaces a number of protocol defined visits which would normally take place onsite, and relocates them in the patient’s home – reducing the burden of the trial on the patient and significantly boosting patient recruitment and maximizing patient retention. With HTS, sites can recruit patients from a wider geographical region and reach a larger patient pool, as well as increase their consenting and retention rates. We have seen that reducing the burden on patients directly increases recruitment by 60% or more and typically maintains patient retention at over 95%, as well as reducing the burden on clinical sites.
Site Nurse Support (SNS) places experienced research nurses into sites to manage trials; this enables each site to focus on patient identification and selection, as well as facilitating performance of all procedures in a timely manner. Placements can be made at single sites, or nursing teams can be pulled together to support sites across whole countries or trials. With SNS, sites have a dedicated resource to identify and screen patients from the increased patient pool effectively.
Together, the impact of these services can result in an increase of up to 600% of completed patients per site.
MRN is a recognized leader in the Home Trial Support clinical trials field. We have a geographical coverage of over 40 countries where we can provide our services. Headquartered in the UK and with offices in North America and Spain, our Vendor Contracts and Management Team (VCMT) have enabled us to conduct Home Trial support visits across all major clinical research countries spanning North America, Europe, Asia and Australasia
CLiX AI automates the interrogation and structure of patient’s narrative data to give CROs and Sponsors a distinct data-driven advantage at critical points throughout the clinical trial life cycle. With the CLiX accelerate solution it is possible to:
• Increase predictability and reduce risk during bid phase feasibility assessment
• Shorten study start-up time by speeding up subject recruitment
• Automate retrospective information sorting for more accurate risk evaluation and mitigation during post-market surveillance
Ok, that’s about it!
CSSi is a Site Performance Company. Our services focus on managing the clinical trial enrollment process and supporting sites to maximize their performance in meeting or exceeding patient accrual timelines. We work with each site individually to ensure that all efforts are specific to each site’s geography, staff availability, past experience and suggestions for the particular study. CSSi utilizes a highly talented in-house staff to deliver these services which allows us to meet your enrollment goals while being mindful of your study budget. We believe that setting each site up for success is best achieved by investing our efforts in developing site-specific enrollment strategies which minimizes costs and maximizes the sponsor’s return on investment. For more information regarding CSSi’s targeted enrollment services and capabilities please contact Chris Trizna, or visit the CSSi website, www.CSSienroll.com.
Bio-Optronics is the creator of Clinical Conductor (CC CTMS), known for generating significant savings with its robust finance capabilities, it is also the leading CTMS for executing collaboratively across multiple clinical trials and sites, including enabling remote workflows. Used by more research sites around the world than any other CTMS, Clinical Conductor is currently managing over 40,000 studies, including a significant percentage of the world’s COVID-19 clinical trials.
CC CTMS is part of the CCTrialSuite, a comprehensive set of integrated, patient-centric clinical research management products that together streamline research operations while maintaining a high degree of compliance. Complementing Clinical Conductor in the suite are several remote workflow enabling solutions. CCPay offers sites the unprecedented ability to both control finances and improve patient satisfaction with real-time payment reimbursements using secure pre-paid payment cards, all controlled remotely from CC CTMS dashboards. While CCText, the only fully CTMS-imbedded, conversational 2-way text messaging solution, has demonstrated clear results with increased patient recruitment, engagement and retention. An expanding set of remote workflow capable solutions include Part 11 compliant CCeReg document management, remote monitoring enabled CCeSource data capture, mobile friendly CCeConsent, and easy to engage remote visits using the HIPAA compliant CCVideo solutions from a single SaaS supplier, Bio-Optronics.
Click here for free access to The Ultimate Guide to Clinical Trial Software!
Also visit www.bio-optronics.com or follow @BioOptronics on Twitter or LinkedIn
